Diabetes

SAN DIEGO — Medication education can help patients with diabetes stay compliant with their medication regimens, according to a new study published in the February issue of the journal Annals of Pharmacotherapy.

RALEIGH, N.C. — Two pharmacy trade groups already have given their blessings to legislation that would support medication therapy management, and a retail pharmacy chain that has made MTM part of its mission is following suit.

Kerr Drug announced its support for the Medication Therapy Management Empowerment Act of 2011, which Sen. Kay Hagan, D-N.C., recently introduced. The National Association of Chain Drug Stores and the National Community Pharmacists Association endorsed the bill last week.

NAPLES, Fla. — Pharmacy's role in the U.S. healthcare system has expanded dramatically over the past two years, thanks to several victories gained through pharmacy care and services.

Speaking at the National Association of Chain Drug Stores' Regional Chain Conference, NACDS board chairman and CVS Caremark president and COO Larry Merlo said that scientific research has further demonstrated how care and services provided by pharmacists and pharmacies have improved health outcomes of patients and cut costs for the healthcare system.

ATLANTA — A drug designed to treat an eye condition caused by diabetes may provide a long-term option for patients, according to Alimera Sciences.

Alimera said in two three-year, phase-3 pivotal clinical trials — collectively known as the FAME Study — of Iluvien, which is designed to treat diabetic macular edema, the drug improved visual acuity among patients.

WASHINGTON — Sen. Kay Hagan, D-N.C., argued before the Senate Thursday around the value that increased access to medication therapy management can deliver to overall health care — that includes cutting into the $290 billion in annual costs associated with medication nonadherence and preventing as many as 89,000 premature deaths.

ALEXANDRIA, Va. — New legislation that supports medication therapy management, which is known to improve patient health outcomes and lower healthcare costs, has been endorsed by the National Association of Chain Drug Stores and the National Community Pharmacists Association.

The Medication Therapy Management Empowerment Act of 2011, which was introduced by Sen. Kay Hagan, D-N.C., builds on legislation that Hagan authored in 2010 and also was co-sponsored by Sens. Al Franken, D-Minn., Sherrod Brown, D-Ohio, and Tim Johnson, D-S.D.

INDIANAPOLIS — Drug maker Eli Lilly and the Juvenile Diabetes Research Foundation will fund research to find ways to regenerate insulin-producing cells in patients with Type 1 diabetes.

The two announced Thursday that ideas included finding ways to grow new insulin-producing cells within a person’s body. Type 1 diabetes, also known as juvenile diabetes, is an autoimmune disease in which the immune system attacks beta cells, the cells that allow the body to produce insulin. As many as 3 million people in the United States have Type 1 diabetes.

BAGSVÆRD, Denmark — A collection of relatively new products helped drive up sales and profits at Novo Nordisk, the Danish drug maker said Wednesday. 

Sales increased by 22% in the North American markets when measured in local currencies, and by 29% when measured in Danish kroner, the company said. Operating profits were $3.5 billion, a 16% increase over 2009.